Cefixime Trihydrate IP 200 mg + Lactic Acid Bacillus 60 MS Uncoated Tablet

Cefixime Trihydrate IP 200 mg + Lactic Acid Bacillus 60 MS Uncoated Tablet is a uncoated tablet formulated with Cefixime Trihydrate 200 mg + Lactic Acid Bacillus 60 MS. The active ingredient profile is Cefixime Trihydrate; Lactic Acid Bacillus, placing the product in the cephalosporin antibiotic + probiotic combination category. Cefixime provides cephalosporin antibacterial activity, while Lactic Acid Bacillus is included as a probiotic adjunct intended to support gastrointestinal microbial balance. The uncoated presentation is an oral solid-dosage form and should be described according to the approved finished-product specification. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad-spectrum claims. Clinical selection should depend on diagnosis, susceptibility or symptom profile, patient-specific factors and the prescriber's judgement. Prescription status, contraindications, precautions, interactions, adverse effects and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life and market-specific regulatory details should be added only from verified product documentation.